- ►bloodjournal.org JE Wagner, JN Barker, TE DeFor, KS Baker, … - Blood, 2002 - Am Soc Hematology To potentially alleviate the shortage of suitable donors and reduce the length
of the search process for unrelated marrow donors, repositories of banked,
HLA-typed UCB have been developed since 1993. 17 , 18 In 1996, Kurtzberg et ... Cited by 478 - Related articles - BL Direct - All 7 versions
- ►hematologylibrary.org [PDF] M Boeckh, TA Gooley, D Myerson, T … - Blood, 1996 - bloodjournal.hematologylibrary.org . reserved Hematology; all rights Copyright 2007 by The American Society of
Suite 200, Washington DC 20036. semimonthly by the American Society of
Hematology, 1900 M St, NW, Blood (print ISSN 0006-4971, online ISSN ... Cited by 376 - Related articles - BL Direct - All 4 versions
- ►hematologylibrary.org [PDF] H Einsele, G Ehninger, H Hebart, KM Wittkowski … - Blood, 1995 - bloodjournal.hematologylibrary.org . reserved Hematology; all rights Copyright 2007 by The American Society of
Suite 200, Washington DC 20036. semimonthly by the American Society of
Hematology, 1900 M St, NW, Blood (print ISSN 0006-4971, online ISSN ... Cited by 320 - Related articles - BL Direct - All 7 versions
- ►bloodjournal.org [PDF] P Salven, S Mustjoki, R Alitalo, K Alitalo, S … - Blood, 2002 - Am Soc Hematology . Hematology; all rights reserved Copyright 2007 by The American Society of DC
20036. by the American Society of Hematology, 1900 M St, NW, Suite 200,
Washington Blood (print ISSN 0006-4971, online ISSN 1528-0020), is ... Cited by 236 - Related articles - BL Direct - All 6 versions
- ►hematologylibrary.org M Boeckh, W Leisenring, SR Riddell, RA … - Blood, 2003 - bloodjournal.hematologylibrary.org Ganciclovir effectively prevents cytomegalovirus (CMV) disease during the first
3 months after allogeneic hematopoietic stem cell transplantation (HSCT) when it
is administered to the patient during engraftment, 1 , 2 for pp65 ... Cited by 187 - Related articles - BL Direct - All 7 versions
DJ Winston, D Wirin, A Shaked, RW Busuttil - The Lancet, 1995 - Elsevier At the time of transplant, patients were randomised to receive either
ganciclovir (6 mg/kg body weight per day intravenously from postoperative day 1
to day 30, then 6 mg/kg per day Monday through Friday until day 100) or ... Cited by 179 - Related articles - BL Direct - All 6 versions
MK Gandhi, R Khanna - The Lancet infectious diseases, 2004 - Elsevier After initial infection, human cytomegalovirus remains in a persistent state
with the host. Immunity against the virus controls replication, although
intermitent viral shedding can still take place in the seropositive ... Cited by 172 - Related articles - All 10 versions
- ►hematologylibrary.org K Cwynarski, J Ainsworth, M Cobbold, S … - Blood, 2001 - bloodjournal.hematologylibrary.org Cytomegalovirus (CMV) disease continues to cause morbidity and mortality after
allogeneic stem cell transplantation (SCT), despite the introduction of routine
screening and antiviral agents. 1 Major risk factors for CMV disease ... Cited by 155 - Related articles - BL Direct - All 6 versions
- ►hematologylibrary.org [PDF] FZ Wang, H Dahl, A Linde, M Brytting, A … - Blood, 1996 - bloodjournal.hematologylibrary.org . reserved Hematology; all rights Copyright 2007 by The American Society of
Suite 200, Washington DC 20036. semimonthly by the American Society of
Hematology, 1900 M St, NW, Blood (print ISSN 0006-4971, online ISSN ... Cited by 142 - Related articles - BL Direct - All 4 versions
- ►hematologylibrary.org AEC Broers, R van der Holt, JWJ van Esser, … - Blood, 2000 - bloodjournal.hematologylibrary.org Cytomegalovirus (CMV) infection is an important cause of morbidity and mortality
in recipients of allogeneic stem cell transplantation (SCT). 1 , 2 CMV can cause
primary infections or may be reactivated in CMV-seropositive recipients and ... Cited by 136 - Related articles - BL Direct - All 7 versions
